文献速递神经肿瘤

超低剂量荧光素钠引导恶性胶质瘤切除术的有效性与安全性

Effectiveness and Safety of Ultra-low-dose Fluorescein Sodium-Guided Resection of Malignant Glioma.
PubMed 文献 · World Neurosurg · 2024-03-01

本研究分析超低剂量荧光素钠(FL)引导恶性胶质瘤切除术的有效性与安全性及其预测胶质瘤病理特征的可能性。60例接受FL引导胶质瘤切除术的患者随机分为试验组(1 mg/kg)和对照组(5 mg/kg),另回顾性纳入30例未接受FL引导手术的胶质瘤患者作为空白对照组。结果显示超低剂量FL引导切除安全有效,FL强度与Ki67阳性率成正比。

要点

  • 试验组、对照组与空白对照组肿瘤全切除率分别为90%(27/30)、86.7%(26/30)、60%(18/30)。
  • 试验组与对照组在切除范围、KPS及术后6个月PFS上均优于空白对照组,但两组间无显著差异。
  • FL强度与Ki67阳性率成正比(P < 0.05),与GFAP未见此关系。

核心结论

  • 超低剂量FL引导恶性胶质瘤切除术安全有效,FL强度与Ki67阳性率成正比,提示其可能在病理检查中用于预测胶质瘤。

研究设计与样本

  • 60例接受FL引导胶质瘤切除术的患者随机分为试验组(1 mg/kg)和对照组(5 mg/kg),另回顾性纳入30例未接受FL引导手术的胶质瘤患者作为空白对照组。

主要发现

  • 试验组、对照组、空白对照组肿瘤全切除率分别为90%(27/30)、86.7%(26/30)、60%(18/30)。
  • 试验组与对照组分别与空白对照组比较,切除范围、KPS及术后6个月PFS差异均有统计学意义(P < 0.05);试验组与对照组之间上述指标差异无统计学意义(P > 0.05)。
  • FL强度与Ki67阳性率成正比(P < 0.05),FL强度与GFAP未见此关系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study analyzed the effectiveness and safety of ultra-low dose fluorescein sodium (FL)-guided malignant glioma resection and its potential to predict the pathological characteristics of glioma. METHODS: Sixty patients who underwent FL-guided glioma resection were randomly divided into test (1 mg/kg) and control (5 mg/kg) groups. A retrospective analysis included 30 patients with gliomas who did not undergo FL-guided surgery; these patients were included as a blank control group. Surgical outcomes, Karnofsky performance scores (KPS), and progression-free survival (PFS) at 6 months postoperatively were compared between the 3 groups. The sensitivity and specificity of FL and the relationship between the intensity of FL and Glial fibrillary acidic protein (GFAP) or Ki-67 expression were compared. RESULTS: The total tumor resection rates in the test, control, and blank control groups were 90% (27/30), 86.7% (26/30), and 60% (18/30), respectively. There were significant differences (P < 0.05) in the extent of resection, KPS, and PFS at 6 months after surgery between the test and control groups and the blank control group; however, no significant differences (P > 0.05) were observed between the test and control groups. The intensity of FL and the Ki67 positivity rate (P < 0.05) were directly proportional, but this relationship was not observed with GFAP. CONCLUSIONS: Ultra-low-dose FL-guided resection of malignant gliomas is safe and effective. The Ki67 positivity rate was directly proportional to the intensity of FL, indicating its potential to predict gliomas during pathological examination.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ling G, Guo T, Guo F, et al. Effectiveness and Safety of Ultra-low-dose Fluorescein Sodium-Guided Resection of Malignant Glioma. World Neurosurg. 2024. PMID: 38432505. doi:10.1016/j.wneu.2024.02.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。